This represents England’s 7th transaction in foot & ankle orthopedics and 11th transaction in orthopedics generally. 

Based in Boca Raton, FL, SEAL produces industry-leading external fixation devices for foot & ankle orthopedics. SEAL’s innovative proprietary devices have proven highly effective in treating a range of lower limb conditions. SEAL is the largest privately-held business in the U.S. focused on external fixation for this market, and many physicians and distributors regard SEAL’s products as the best. 

SEAL’s leadership position has been driven by its design of features that afford physicians much greater speed, ease of use, and flexibility in assembling frames onto patients. Enovis’ acquisition of the product portfolio demonstrates their continued dedication to the foot & ankle space, as they aim to become a leader in the market by offering innovative and comprehensive solutions for surgeons and their patients. 

“It was crucial to find a buyer committed to excellence and innovation for this product line, and we believe that Enovis will be able to grow the business significantly,” said Nick Riccione, President and CEO of DNE. Riccione added, “England’s expertise and relationships in the orthopedic extremity sector helped us prepare for due diligence and navigate the process of securing an ideal buyer in Enovis. This transaction lays the foundation for this business to gain global reach.”